We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.

A long-term HIV survivor reflects on the gaps and challenges that remain to end the epidemic.

A founding member of the Congressional HIV/AIDS Caucus and the president of AIDS United encourage everyone to know their status.

An HIV-negative writer asks: Why does resistance persist to the “Undetectable = Untransmittable” message?

An update from the Trump administration’s NHAS Federal Interagency Workgroup.

A researcher responds to expanded approval of Truvada as pre-exposure prophylaxis by the Food and Drug Administration.

A guide from the Centers for Disease Control and Prevention (CDC) for state and local health departments.

HIV groups ask: If Silence=Death, where is the HIV community’s voice resisting the war against immigrants in the United States?

Building a diverse biomedical sciences workforce is a critical step in reducing the burden of cancer for an increasingly diverse America.